Editorial: Β-Defensins and crohn's disease: Confusion from counting copies

American Journal of Gastroenterology

Volumn 105, Issue 2, 2010, Pages 360-362

  Hollox, Edward J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; BETA DEFENSIN 4; CASPASE RECRUITMENT DOMAIN PROTEIN 15; BETA DEFENSIN; DEFB4 PROTEIN, HUMAN;

CONTROLLED STUDY; CROHN DISEASE; GENETIC VARIABILITY; HUMAN; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; GENE DOSAGE; GENETIC PREDISPOSITION; GENETICS; NOTE; PATHOLOGY;

BETA-DEFENSINS; CROHN DISEASE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 76349116970     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.573     Document Type: Review

References (16)

1. Stone M A, Mayberry JF, Baker R. Prevalence and management of infam-matory bowel disease: a cross-sectional study from central England. Eur J Gastroenterol Hepatol 2003;15:1275-1280
2. Bentley R W, Pearson J, Gearry R B et al. Association of higher DEFB4 genomic copy number with Crohn's disease. Am J Gastroenterol 2010;105:354-359
3. Fellermann K, Stange D E, Schaefeler E et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 2006;79:439-448
4. Tomas G A, Rhodes J, Green JT et al. Role of smoking in inf ammatory bowel disease: implications for therapy. Postgrad Med J 2000;76:273-279
5. Barrett JC, Hansoul S, Nicolae DL 61 co-authors Genome-wide association def nes more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40:955-962
6. Van Limbergen J, Wilson D C, Satsangi J. The genetics of Crohn's disease. Annu Rev Genomics Hum Genet 2009;10:89-116.
7. Voss E, Wehkamp J, Wehkamp K et al. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem 2006;281:2005-2011
8. Ramasundara M, Leach ST, Lemberg D A, Day A S. Defensins and infam-mation: the role of defensins in infammatory bowel disease. J Gastroen-terol Hepatol 2009; 24: 202-208
9. Jansen PA, Rodijk-Olthuis D, Hollox EJ et al. Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin. PLoS One 2009;4:e4725.
10. Hollox E J, Armour JA, Barber JC. Extensive normal copy number variatio n o f a beta-defensin antimicrobial-gene cluster. Am J Hum Genet 2003; 73: 591-600.
11. Hollox E J, Barber J C, Brookes A J et al. Defensins and the dynamic genome: what we can learn from structural variation at human chromosome band 8p23.1. Genome Res 2008;18:1686-1697
12. Aldhous MC, Noble CL, Satsangi J. Dysregulation of human beta-defensin-2 protein in infammatory bowel disease. PLoS One 2009;4:e6285.
13. Muramatsu T, Matsushita S, Arai Het al. Alpha 1-antichymotrypsin gene polymorphism and risk for Alzheimer's disease. J Neural Transm 1996;103:1205-1210
14. Yoshiiwa A, Kamino K, Yamamoto H et al. Alpha 1-antichymotrypsin asa risk modif er for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers. Ann Neurol 1997;42:115-117
15. Bertram L, McQueen M, Mullin K et al. The AlzGene Database. Alzheimer Research Forum. Available at: http://www.alzgene.org. Accessed 01 September 2009.
16. Clayton D G, Walker N M, Smyth D J, et al. Population structure, dif erential bias and genomic control in a large-scale, case-control association study. Nat Genet 2005;37:1243-1246